Skip to main content

Table 1 Baseline characteristics for the CATIE and each of the RCTs. Proportions are presented for categorical variables and means and standard deviations in parenthesis are presented for continuous variables

From: Calibrated meta-analysis to estimate the efficacy of mental health treatments in target populations: an application to paliperidone trials for treatment of schizophrenia

 

Target Population

Randomized Controlled Trials

 

CATIE

NCT00074477

NCT00210548

NCT00101634

NCT00590577

N

1458

243

349

511

635

Female (%)

26.1

32.9

30.7

33.7

32.8

Race (%)

 White

59.9

71.2

40.4

66.9

53.9

 African-American

35.1

16.5

38.7

28.6

30.2

 Other

5.0

12.3

20.9

4.5

15.9

Age, year (%)

  ≤ 30

21.3

26.3

21.8

21.7

24.7

 30–40

24.0

28.8

30.1

24.9

28.2

 40–50

35.3

32.9

30.4

32.9

32.4

  > 50

19.4

11.9

17.8

20.5

14.6

Onset age, year (%)

  ≤ 20

30.2

31.7

35.1

31.6

32.9

 20–30

46.2

41.2

43.1

40.7

43.1

 30–40

16.1

20.4

16.1

18.1

19.4

 > 40

7.5

6.7

5.7

9.6

4.6

Weight, kg (%)

  ≤ 70

18.3

46.3

32.1

35.0

35.3

 70–80

20.9

19.0

17.8

22.5

26.5

 80–90

18.5

18.6

15.8

15.9

14.0

 90–100

16.0

10.7

13.2

9.4

13.1

 100–110

12.5

3.3

7.7

7.0

3.6

  > 110

13.7

2.1

13.5

10.2

7.6

PANSS (mean [SD], [min, max])

75.65 (17.57)

[31, 140]

87.86 (12.20)

[55, 120]

91.09 (11.80)

[70, 120]

90.85 (12.03)

[70, 120]

87.07 (11.20)

[61, 131]